Peregrine Pharmaceuticals, Inc. to Present at Stifel Nicolaus Healthcare Conference September 5, 2012 at 2:40 PM EDT
Published: Aug 30, 2012
TUSTIN, CA--(Marketwire - August 29, 2012) -
Peregrine Pharmaceuticals News
Peregrine's presentation will be webcast live and available for replay until September 19, 2012 at: http://ir.peregrineinc.com/events.cfm
About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing multiple clinical programs in cancer and infectious diseases with its lead product candidate bavituximab and novel brain cancer agent Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.
Christopher Keenan or Jay Carlson